Prospective, Open-Label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients (RENEW)

This study is ongoing, but not recruiting participants.
Information provided by EMD Serono

Please refer to this study by its ClinicalTrials.gov identifier: NCT00262314

Locations

Sponsors and Collaborators

Investigators